BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17878485)

  • 1. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
    Ajani JA; Correa AM; Swisher SG; Wu TT
    J Clin Oncol; 2007 Sep; 25(27):4315-6. PubMed ID: 17878485
    [No Abstract]   [Full Text] [Related]  

  • 2. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative therapy in esophageal and stomach carcinoma].
    Stahl M; Wilke H; Meyer HJ
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative radiochemotherapy in gastric cancer: another ongoing shift from adjuvant to neoadjuvant?
    Allal AS
    J Clin Oncol; 2005 Jun; 23(16):3870; author reply 3870-1. PubMed ID: 15923598
    [No Abstract]   [Full Text] [Related]  

  • 8. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
    [No Abstract]   [Full Text] [Related]  

  • 10. (Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.
    Wilke H; Lordick F; Meyer HJ; Stahl M
    Dig Surg; 2013; 30(2):112-8. PubMed ID: 23867587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
    Siersema PD; van Hillegersberg R
    Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized adenocarcinoma of the esophagogastric junction--is there a standard of care?
    Power DG; Reynolds JV
    Cancer Treat Rev; 2010 Aug; 36(5):400-9. PubMed ID: 20117883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic therapy of esophago-gastric tumors.
    Lambert R
    Endoscopy; 1992; 24(1-2):24-33. PubMed ID: 1373114
    [No Abstract]   [Full Text] [Related]  

  • 15. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
    Veuillez V; Rougier P; Seitz JF
    Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality therapy of localized gastric and esophageal cancers.
    Das P; Fukami N; Ajani JA
    J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 18. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
    Mönig SP; Berlth F; Chon SH
    Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.